Intas
-
Intas, Axantia sign exclusive license and supply agreement for Ranibizumab biosimilar in Middle East
Axantia will register, hold the marketing authorisation and commercialise Ranibizumab Intas Pharmaceuticals has signed an exclusive license and supply agreement…
Read More »